Brussels, Belgium

Francis Brasseur


Average Co-Inventor Count = 3.8

ph-index = 4

Forward Citations = 47(Granted Patents)


Company Filing History:


Years Active: 1996-2013

Loading Chart...
16 patents (USPTO):Explore Patents

Title: The Innovative Mind of Francis Brasseur: Pioneering Cancer Research

Introduction: Francis Brasseur is a notable inventor based in Brussels, Belgium, recognized for his significant contributions to cancer research. With an impressive portfolio of 16 patents, he focuses on the development of innovative therapies aimed at combatting tumors and understanding their complexities.

Latest Patents: Among his latest inventions are groundbreaking patents related to tumour rejection antigens. One notable patent details polypeptides comprising an unbroken sequence of amino acids from SEQ. ID. NO. 1 or 2, which possess the ability to complex with major histocompatibility complex molecules, specifically HLA-A2 and preferably HLA-A2.1. Another important patent introduces isolated peptides derived from MAGE-C2, including nucleic acid molecules that encode these peptides. This patent also encapsulates expression vectors, host cells transformed with these vectors, and tetramers that include the peptides, HLA molecules, beta-microglobulin, and binding partners. Additionally, this invention covers methods for utilizing these peptides and nucleic acid molecules, as well as cytolytic T cells that recognize the peptides in conjunction with HLA molecules.

Career Highlights: Francis Brasseur is affiliated with the Ludwig Institute for Cancer Research Limited, where he engages in cutting-edge research to innovate cancer treatment methodologies. His work is characterized by a commitment to understanding and developing new therapeutic strategies, making a notable impact in the field of oncology.

Collaborations: Throughout his career, Brasseur has collaborated with esteemed colleagues, notably Thierry R. Boon-Falleur and Christophe Lurquin. These partnerships have enabled him to advance his research and further the development of novel cancer therapies.

Conclusion: Francis Brasseur exemplifies the spirit of innovation in medical research, particularly in cancer therapy. His patents reflect a dedication to improving patient outcomes through scientific advancements. As he continues to work at the Ludwig Institute for Cancer Research Limited, the impact of his contributions will surely resonate in the field of oncology for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…